Randomized controlled trialHumanClinical Trial, Phase II
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
The lancet. Diabetes & endocrinology, 2025 Aug. Coskun T, Wu Q, Schloot NC and 4 others.
Study type
Randomized controlled trial · Clinical Trial, Phase II
Subjects
Human participants (PubMed MeSH: Humans)
Journal
The lancet. Diabetes & endocrinology
Published
2025 Aug
PubMed
Indexed under
MeSH terms assigned by the National Library of Medicine.
HumansDiabetes Mellitus, Type 2MaleMiddle AgedFemaleDouble-Blind MethodBody CompositionAdultAgedHypoglycemic AgentsGlucagon-Like PeptidesAdolescent
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page